GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

Market Cap	550.96B
Revenue (ttm)	37.49B
Net Income (ttm)	9.28B
Shares Out	169.41M
EPS (ttm)	54.76
PE Ratio	59.40
Forward PE	52.99
Dividend	42.00 (1.25%)
Ex-Dividend Date	May 30, 2025

Volume	2,694
Average Volume	14,316
Open	3,305.05
Previous Close	3,366.50
Day's Range	3,238.00 - 3,324.60
52-Week Range	1,924.30 - 3,515.95
Beta	0.04
RSI	53.90
Earnings Date	Aug 1, 2025

About BOM:500660

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. It provides vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostr...

• Industry: Pharmaceutical Preparations
• Founded: 1924
• Employees: 3,113
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500660

Financial Performance

In 2024, BOM:500660's revenue was 37.49 billion, an increase of 8.56% compared to the previous year's 34.54 billion. Earnings were 9.28 billion, an increase of 57.23%.